Alaunos Therapeutics
TCRT
156 hedge funds and large institutions have $512M invested in Alaunos Therapeutics in 2015 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 57 increasing their positions, 35 reducing their positions, and 17 closing their positions.
112% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 17
63% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 35
13% more funds holding
Funds holding: 138 → 156 (+18)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
7% less call options, than puts
Call options by funds: $25.1M | Put options by funds: $26.9M
10% less capital invested
Capital invested by funds: $570M → $512M (-$58.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21.8M |
| 2 |
State Street
Boston,
Massachusetts
|
+$10.6M |
| 3 |
MVP
Miller Value Partners
Sarasota,
Florida
|
+$9.27M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$8.81M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$6.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO)
Austin,
Texas
|
-$105M |
| 2 |
MP
MSD Partners
New York
|
-$3.86M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.22M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$3.1M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.58M |
TCRT Hedge Fund Activity: Q4 2015 in Review
156 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q4 2015, worth a combined $512M — down 10% from $570M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new TCRT positions and 17 closed out — a net gain of 19 holders — while 57 added to existing stakes and 35 trimmed.
The largest buyer was Vanguard Group, adding an estimated $21.8M. The largest seller was University of Texas/Texas AM Investment Management Co (UTIMCO), cutting an estimated $105M.
- 156 institutional investors held Alaunos Therapeutics (TCRT) as of Q4 2015, up from 138 in Q3 2015.
- Funds reported $512M of Alaunos Therapeutics stock for Q4 2015, down 10% quarter-over-quarter.
- 36 funds opened new Alaunos Therapeutics positions in Q4 2015 and 17 closed out, a net change of +19 holders.
- The largest Alaunos Therapeutics buyer in Q4 2015 was Vanguard Group, an estimated $21.8M added.
- The largest Alaunos Therapeutics seller in Q4 2015 was University of Texas/Texas AM Investment Management Co (UTIMCO), an estimated $105M sold.
Based on aggregated 13F filings for Q4 2015.